Results 11 to 20 of about 1,396 (180)
Veterinary Dermatology, Volume 34, Issue 6, Page 586-596, December 2023., 2023 Background – In clinical practice, the diagnosis of otitis externa (OE) normally is based on otoscopic examination and cytological findings, followed by empirical treatment with topic drugs. Biofilm‐producing bacteria are frequently present in OE, even if its presence is often underdiagnosed. Hypothesis/Objectives – The primary aim of this study was to
Luca Luciani +6 more
wiley +1 more source
Veterinary Dermatology, Volume 33, Issue 4, Page 316-e73, August 2022., 2022 Abstract Background Pseudomonas aeruginosa is the most commonly isolated bacterium from skin lesions of dogs with post‐grooming furunculosis (PGF). It is frequently found in human hair and skin care products, and may pose a health risk to consumers. Information regarding the prevalence of P. aeruginosa contamination of dog grooming products is lacking.
Elad Perry +5 more
wiley +1 more source
Veterinary Dermatology, Volume 32, Issue 5, Page 456-e124, October 2021., 2021 Background – Ceftazidime (CAZ) solutions are being used based on anecdotal reports for otitis externa complicated by multidrug‐resistant Pseudomonas aeruginosa (MDR PA). The chemical and microbiological stability of these proposed compounded solutions have not been evaluated, and likely are affected by the diluent and storage duration or temperature ...
Sarah E. Hoff +4 more
wiley +1 more source
Veterinary Dermatology, Volume 27, Issue 5, Page 391-e98, October 2016., 2016 Background– Pseudomonas aeruginosa (PA) may cause suppurative otitis externa with severe inflammation and ulceration in dogs. Multidrug resistance is commonly reported for this organism, creating a difficult therapeutic challenge. Objective– The aim of this study was to evaluate the in vitro antimicrobial activity of a gel containing 0.5 µg/mL of ...
Giovanni Ghibaudo +6 more
wiley +1 more source
, 2018 目的了解医院血培养病原菌的菌种分布及常见病原菌的耐药情况,为临床用药提供参考依据。方法对2017年1～12月临床送检的血培养标本进行回顾性统计分析。结果 4 447份血培养标本共分离出病原菌225株,阳性检出率为5. 1%。主要病原菌:大肠埃希菌82株占36. 4%、凝固酶阴性葡萄球菌31株占13. 8%、肺炎克雷伯菌17株占7. 6%、铜绿假单胞菌10株占4.
廖蕴惠, 赵军
core +1 more source
Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs : insights from experimental studies, mechanistic actions to clinical applications [PDF]
, 2021 Whilst the popular use of herbal medicine globally, it poses challenges in managing potential drug-herb interaction. There are two folds of the drug-herb interaction, a beneficial interaction that may improve therapeutic outcome and minimise the toxicity
Fu, Ling +5 more
core +1 more source
Veterinary Dermatology, Volume 36, Issue 2, Page 148-158, April 2025.Background – Biofilm production by canine otitis externa (COE) pathogens and resistance development to multiple antimicrobials are commonly reported problems in veterinary practice. The use of adjuvants to disrupt biofilms may be a viable adjunctive therapy.
Bhumika F. Savaliya +3 more
wiley +1 more source
Progress in Research on Bacteriophage Receptor-Binding Proteins and Host Range Extension [PDF]
, 2023 Phages are one of the most diverse and widely distributed organisms on the earth today, and have great advantages in eliminating bacteria, especially multi-drug resistant bacteria that are widespread at present.
LI Fan, YU Zhenxing, ZHANG Ming, LIN Hong, LI Xuepeng, LI Jianrong, ZHANG Defu
core +1 more source
Veterinary Dermatology, Volume 35, Issue 3, Page 325-336, June 2024.Background – Norway spruce (Picea abies) resin‐based products are used in human medicine. A resin‐based otic rinse also could be useful in supportive care of canine otitis externa (COE), yet information on its antimicrobial effect against canine pathogens or ototoxicity is lacking.
Elina Aimo‐Koivisto +5 more
wiley +1 more source
Optimization of beta lactam antibiotics regimens against bloodstream infection caused by Pseudomonas aeruginosa [PDF]
, 2017 目的制定某院beta内酰胺类在铜绿假单胞菌(PA)血流感染中的治疗方案。方法收集某院2015年至2016年血培养中铜绿假单胞菌共64株,测定; beta内酰胺类(哌拉西林/他唑巴坦,头孢他啶,头孢吡肟,亚胺培南,美罗培南)对铜绿假单胞菌的最低抑菌浓度(MIC)。用蒙特卡洛模拟计算多种治疗; 方案的达标率(PTA)和累积反应分数(CFR)。结果经验治疗时,哌拉西林/他唑巴坦4.5 g(q6 h),头孢他啶2 g(q8 h),头孢吡肟2; g(q8 h),亚胺培南1 g(q6 h),美罗培南1 g(q8 h,
于迪 +4 more
core